LPV/r200+50mg heat/st tab/PAC-120 No CTN

General description:
Lopinavir 200mg + Ritonavir 50mg film coated heat stable tablets, in a bottle pack of 120 without outer carton

Technical specifications:
Each film coated tablet contains a fixed boosted protease inhibitor combination of Lopinavir 200mg + Ritonavir 50mg in a heat stable formulation.

Therapeutic class:
Protease Inhibitors (PI)

Dosage, Instructions for use:
For more details, please see WHO treatment guidelines www.who.int/hiv/pub/guidelines/en/index.html and WHO Essential Medicines Library www.who.int/emlib/ or your regional/national guidelines.

Details about paediatric dosage schemes can be found at http://www.who.int/hiv/topics/paediatric/en/index.html

WHO generic tool for assessing paediatric ARV dosing
http://www.who.int/hiv/paediatric/generictool/en/

Indications
Management of HIV-1 infection in children and adults in combination with at least two other antiretroviral drugs. By mouth (oral) PO.

Shelf life:
24 months

Storage conditions:
Do not store above 30°C.

Other available formulations
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.